Menu

Physician Editorial

About Physician Editorial

http://physicianeditorial.com

Posts by Physician Editorial:

Novartis announces new data on the effects of investigational RLX030 on kidney blood flow in chronic heart failure patients

, ,

Study result signals potential kidney benefit with RLX030;1 future studies will further explore this impact Kidney dysfunction affects approximately 30 percent of US heart failure patients and is associated with worse prognosis of these patients2 Data presented at a late-breaking session at the 17th annual Heart Failure Society of America (HFSA) Scientific Meeting in Orlando, […]

Accuray to Showcase Clinical Utilization and Adoption of its Latest Advanced Product Platforms at ASTRO 2013

, , , ,

Accuray to Showcase Clinical Utilization and Adoption of its Latest Advanced Product Platforms at ASTRO 2013 World’s Largest Annual Gathering of the Radiation Oncology Community Provides Multiple Opportunities to Learn about the CyberKnife® M6™ Series and the TomoTherapy® H™ Series Systems SUNNYVALE, Calif., September 22, 2013 and ASTRO 2013 (Atlanta)– Accuray Incorporated (Nasdaq: ARAY) announced today […]

Monaco 5 – Treatment Planning Software from Elekta

, , , , ,

Accuracy accelerated. Monaco is a complete treatment planning system featuring a new workflow and system architecture designed to improve processing speed and enhance planning productivity. Monaco features the accuracy of Monte Carlo plus the speed of the Collapsed Cone algorithms to help clinicians plan for their patients. Greater confidence to deliver the right dose to […]

Elekta Announces Monaco 5.0 – Comprehensive Radiation Treatment Planning Capabilities Brought Together in One System

, , , ,

New workflow and system architecture designed to improve processing speed, enhance planning productivity ATLANTA, Sept. 21 /PRNewswire/ – Elekta today announced Monaco® 5.0, which consolidates support for all of the most clinically useful delivery techniques in a single treatment planning system, and features refinements to planning speed and precision. “This latest Monaco release brings together […]

Nucletron, an Elekta Company, Introduces Esteya, Electronic Brachytherapy for Treating Skin Cancer

, , , ,

ATLANTA, Sept. 21 – Nucletron, an Elekta company, and the world leader in brachytherapy, has launched Esteya®, a new approach for treating patients with skin cancer. Over the last 30 years, more people were diagnosed with skin cancer worldwide than all other cancers combined, making it the most common type of cancer[1]. This represents a […]

Ventana to collaborate with Boehringer Ingelheim on the development of companion diagnostic tests

, , , ,

TUCSON, Arizona and INGELHEIM, Germany, 19 September 2013 – Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, and Boehringer Ingelheim (BI) announced today that they have entered into an agreement to collaborate on the development of companion diagnostic tests for Boehringer Ingelheim Oncology programmes. As part of the agreement, Ventana will utilize its […]

Major Study: Minimally Invasive Prostate Surgery Safer than Open Surgery

, , , , ,

Robotic-Assisted Surgery Significantly Reduces Complications Compared to Open Surgery SUNNYVALE, Calif., Sept. 16, 2013 (GLOBE NEWSWIRE) — An independent study published online in the journal Urology found that minimally invasive surgery for prostate cancer significantly reduces complications when compared to open surgery. The study found that minimally invasive surgery for prostate cancer, including laparoscopic and robotic-assisted surgery, was associated […]

Sandoz supports tuberculosis awareness film in cooperation with Indian Ministry of Health

, ,

Mumbai, India, September 12, 2013 – Partnerships with local health authorities support community engagement programs to raise awareness, provide preventive solutions and counter many myths surrounding tuberculosis. Sandoz Global TB, based out of India, has collaborated with the Indian Government’s Ministry of Health to prepare an awareness film on the management of tuberculosis in public health centers […]

United Therapeutics Announces FDA Acceptance of Second Resubmission of Oral Treprostinil NDA

, ,

SILVER SPRING, Md., Sept. 11, 2013 /PRNewswire/ — United Therapeutics Corporation (NASDAQ: UTHR) announced today that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of the new drug application (NDA) for treprostinil diolamine extended release tablets (oral treprostinil) for the treatment of pulmonary arterial hypertension. The FDA classified the resubmission as a […]

«‹ 91 92 93 94›»